{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:11:18Z","timestamp":1790266278247,"version":"4.1.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2,20]]},"DOI":"10.1097\/cm9.0000000000000070","type":"journal-article","created":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T01:50:02Z","timestamp":1549417802000},"page":"454-465","source":"Crossref","is-referenced-by-count":51,"title":["Long noncoding RNA LINC00520 prevents the progression of cutaneous squamous cell carcinoma through the inactivation of the PI3K\/Akt signaling pathway by downregulating EGFR"],"prefix":"10.1097","volume":"132","author":[{"given":"Xue-Ling","family":"Mei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210129","doi-asserted-by":"crossref","first-page":"f6153","DOI":"10.1136\/bmj.f6153","article-title":"Interventions for non-metastatic squamous cell carcinoma of the skin: systematic review and pooled analysis of observational studies","volume":"347","author":"Lansbury","year":"2013","journal-title":"BMJ"},{"key":"R2-10-20210129","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1159\/000430115","article-title":"Ginsenoside rh2 inhibits cancer stem-like cells in skin squamous cell carcinoma","volume":"36","author":"Liu","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"R3-10-20210129","doi-asserted-by":"crossref","first-page":"e34422","DOI":"10.1371\/journal.pone.0034422","article-title":"Analysis of Tp53 codon 72 polymorphisms, Tp53 mutations, and HPV infection in cutaneous squamous cell carcinomas","volume":"7","author":"Loeb","year":"2012","journal-title":"PLoS One"},{"key":"R4-10-20210129","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1097\/DSS.0000000000000488","article-title":"Lymph node metastasis in cutaneous head and neck squamous cell carcinoma","volume":"41","author":"Silberstein","year":"2015","journal-title":"Dermatol Surg"},{"key":"R5-10-20210129","first-page":"45","article-title":"Cutaneous squamous cell carcinoma","volume":"64","author":"Mateus","year":"2014","journal-title":"Rev Prat"},{"key":"R6-10-20210129","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/s00105-013-2734-7","article-title":"Cutaneous squamous cell carcinoma: a review with consideration of special patient groups","volume":"65","author":"Hillen","year":"2014","journal-title":"Hautarzt"},{"key":"R7-10-20210129","doi-asserted-by":"crossref","first-page":"6582","DOI":"10.1158\/1078-0432.CCR-14-1768","article-title":"Mutational landscape of aggressive cutaneous squamous cell carcinoma","volume":"20","author":"Pickering","year":"2014","journal-title":"Clin Cancer Res"},{"key":"R8-10-20210129","first-page":"2526","article-title":"LncRNA HOXD-AS1 promotes melanoma cell proliferation and invasion by suppressing RUNX3 expression","volume":"7","author":"Zhang","year":"2017","journal-title":"Am J Cancer Res"},{"key":"R9-10-20210129","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2217\/epi-2015-0012","article-title":"Expression profiles of long noncoding RNAs in cutaneous squamous cell carcinoma","volume":"8","author":"Sand","year":"2016","journal-title":"Epigenomics"},{"key":"R10-10-20210129","doi-asserted-by":"crossref","first-page":"81981","DOI":"10.18632\/oncotarget.11962","article-title":"LINC00520 is induced by Src, STAT3, and PI3K and plays a functional role in breast cancer","volume":"7","author":"Henry","year":"2016","journal-title":"Oncotarget"},{"key":"R12-10-20210129","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.prp.2014.05.006","article-title":"Pattern of TGFbeta receptor 1 expression differs between kras-mutated keratoacanthomas and squamous cell carcinomas of the skin","volume":"210","author":"Berger","year":"2014","journal-title":"Pathol Res Pract"},{"key":"R13-10-20210129","doi-asserted-by":"crossref","first-page":"72","DOI":"10.12788\/j.sder.0083","article-title":"Prospects for personalized targeted therapies for cutaneous squamous cell carcinoma","volume":"33","author":"Mavropoulos","year":"2014","journal-title":"Semin Cutan Med Surg"},{"key":"R14-10-20210129","doi-asserted-by":"crossref","first-page":"874571","DOI":"10.1155\/2011\/874571","article-title":"Inhibition of epidermal growth factor receptor and PI3K\/Akt signaling suppresses cell proliferation and survival through regulation of Stat3 activation in human cutaneous squamous cell carcinoma","volume":"2011","author":"Bito","year":"2011","journal-title":"J Skin Cancer"},{"key":"R15-10-20210129","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1186\/1471-2105-7-469","article-title":"Evaluating different methods of microarray data normalization","volume":"7","author":"Fujita","year":"2006","journal-title":"BMC Bioinformatics"},{"key":"R17-10-20210129","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/bjc.2014.432","article-title":"Dasatinib worsens the effect of cetuximab in combination with fractionated radiotherapy in FaDu- and A431-derived xenografted tumours","volume":"111","author":"Baro","year":"2014","journal-title":"Br J Cancer"},{"key":"R18-10-20210129","first-page":"1709","article-title":"Squamous cell carcinoma of the skin (non-metastatic)","volume":"2014","author":"Green","year":"2014","journal-title":"BMJ Clin Evid"},{"key":"R19-10-20210129","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/jso.23731","article-title":"The incidence and risk factors of metastasis for cutaneous squamous cell carcinoma\u2013implications on the T-classification system","volume":"110","author":"Brougham","year":"2014","journal-title":"J Surg Oncol"},{"key":"R20-10-20210129","doi-asserted-by":"crossref","first-page":"61282","DOI":"10.18632\/oncotarget.18058","article-title":"Clinical roles of the aberrantly expressed lncRNAs in lung squamous cell carcinoma: a study based on RNA-sequencing and microarray data mining","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"R21-10-20210129","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/hed.21802","article-title":"EGFR expression in advanced head and neck cutaneous squamous cell carcinoma","volume":"34","author":"Sweeny","year":"2012","journal-title":"Head Neck"},{"key":"R22-10-20210129","doi-asserted-by":"crossref","first-page":"bcr2013203226","DOI":"10.1136\/bcr-2013-203226","article-title":"Squamous cell carcinoma of external auditory canal lacking epidermal growth factor receptor protein overexpression, in an elderly Omani with oculocutaneous albinism treated with palliative radiotherapy","volume":"2014","author":"Furrukh","year":"2014","journal-title":"BMJ Case Rep"},{"key":"R23-10-20210129","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000367959","article-title":"Dysregulation of epidermal growth factor receptor in actinic keratosis and squamous cell carcinoma","volume":"46","author":"Joseph","year":"2015","journal-title":"Curr Probl Dermatol"},{"key":"R24-10-20210129","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1600-0625.2011.01334.x","article-title":"Low incidence of EGFR and HRAS mutations in cutaneous squamous cell carcinomas of a German cohort","volume":"20","author":"Mauerer","year":"2011","journal-title":"Exp Dermatol"},{"key":"R25-10-20210129","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1158\/1078-0432.CCR-14-1773","article-title":"Genomic analysis of metastatic cutaneous squamous cell carcinoma","volume":"21","author":"Li","year":"2015","journal-title":"Clin Cancer Res"},{"key":"R26-10-20210129","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.ejca.2015.06.110","article-title":"Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline","volume":"51","author":"Stratigos","year":"2015","journal-title":"Eur J Cancer"},{"key":"R27-10-20210129","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.prp.2011.03.002","article-title":"Epidermal growth factor receptor (EGFR) and squamous cell carcinoma of the skin: molecular bases for EGFR-targeted therapy","volume":"207","author":"Uribe","year":"2011","journal-title":"Pathol Res Pract"},{"key":"R28-10-20210129","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.oraloncology.2014.11.012","article-title":"Targeting the PI3K\/AKT\/mTOR pathway in squamous cell carcinoma of the head and neck","volume":"51","author":"Simpson","year":"2015","journal-title":"Oral Oncol"},{"key":"R29-10-20210129","doi-asserted-by":"crossref","first-page":"722","DOI":"10.3892\/ol.2012.1069","article-title":"Baicalein induces apoptosis in esophageal squamous cell carcinoma cells through modulation of the PI3K\/Akt pathway","volume":"5","author":"Zhang","year":"2013","journal-title":"Oncol Lett"},{"key":"R30-10-20210129","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jaad.2013.05.011","article-title":"An evolving paradigm for the workup and management of high-risk cutaneous squamous cell carcinoma","volume":"69","author":"O\u2019Bryan","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"R31-10-20210129","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s00105-016-3875-2","article-title":"Cutaneous squamous cell carcinoma","volume":"67","author":"Leiter","year":"2016","journal-title":"Hautarzt"},{"key":"R32-10-20210129","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/IOP.0b013e3182831bf3","article-title":"Targeted therapy for orbital and periocular basal cell carcinoma and squamous cell carcinoma","volume":"29","author":"Yin","year":"2013","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"R33-10-20210129","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3892\/ol.2015.3843","article-title":"High mobility group box 1 regulates tumor metastasis in cutaneous squamous cell carcinoma via the PI3K\/AKT and MAPK signaling pathways","volume":"11","author":"Sun","year":"2016","journal-title":"Oncol Lett"},{"key":"R34-10-20210129","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s11864-014-0280-x","article-title":"Therapy of advanced squamous cell carcinoma of the skin","volume":"15","author":"Bejar","year":"2014","journal-title":"Curr Treat Options Oncol"},{"key":"R35-10-20210129","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1080\/10717544.2017.1386729","article-title":"GE11 peptide conjugated selenium nanoparticles for EGFR targeted oridonin delivery to achieve enhanced anticancer efficacy by inhibiting EGFR-mediated PI3K\/AKT and Ras\/Raf\/MEK\/ERK pathways","volume":"24","author":"Pi","year":"2017","journal-title":"Drug Deliv"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00029330-201902200-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,30]],"date-time":"2021-01-30T12:13:00Z","timestamp":1612008780000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00029330-201902200-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,20]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000000070","relation":{},"ISSN":["0366-6999"],"issn-type":[{"value":"0366-6999","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2,20]]}}}